¹Oral Antiviral numbers presented do not include those allocated to Community Pharmacy Enhanced Services Network. These Oral Antiviral courses were bulk ordered and distribution to individual site locations is managed by respective Federal Retail Pharmacy Therapeutic Program (FRPTP) partners, VDH does not have visibility of course distribution to each region.

*Please see Page 4 for the Outpatient Therapeutic Portfolio- Jurisdiction Allocations for more detail.

Therapeutics Allocation Sweep

HHS has initiated a new policy practice to sweep any unordered Therapeutic product back into the Federal Pool beginning the end of this week (Saturday, March 19 – 8:00 am ET). This allows HHS to centralize unused Therapeutic inventory and more efficiently direct doses to those states that need them. This should have minimal impact on VDH’s ability to fulfill the Commonwealth’s COVID-19 Therapeutic needs and the process used by our providers and pharmacy partners to obtain them. Moving forward, at the end of each week, any remaining Therapeutic Inventory will be swept by HHS.
Note, EVUSHELD will be swept at the end of each month due to its monthly allocation. VDH still requires that all Therapeutic requests be submitted by Tuesdays at noon.

Therapeutics Ordering Process for Federal Retail Pharmacy Therapeutic Program (FRPTP) Partners Continuing our efforts to increase access to therapeutic treatments, Virginia Department of Health (VDH) rolled out our new oral antiviral ordering process for Federal Retail Pharmacy Therapeutic Program (FRPTP) partners. FRPTP partners now have the option to allow their individual locations to manage their own oral antivirals requests through VaxMaX OR our FRPTP partners can opt to request oral antivirals in bulk for their respective chains by completing a REDCap Bulk Order Survey.

For additional questions, contact covid19therapeutics@vdh.virginia.gov.

Federal Initiatives for Oral Antivirals

• Test to Treat Program
  • Select Federal Retail Pharmacy Partnership (FRPP) with existing clinics located inside of their facilities. will now be able to order the oral antivirals Paxlovid and Monulpiravir directly from the federal government.
  • VDH confirmed two pharmacy chains are participating in the Test to Treat Program in Virginia: CVS and Kroger.
  • Please note only these pharmacies with clinics participate in this program.
    • FRPP pharmacy locations will increase opportunities for successful end-to-end Test and Treat model by co-locating testing, provider, and treatment in single location.
    • Reduce barriers to rapid linkage to treatment for high-risk COVID-19+ individuals.
    • Opens additional pathway of direct ordering of oral antivirals for eligible retail health clinic locations.
    • Linkage to a clinical evaluation by licensed healthcare provider after positive result to provide prescription.

• Long-term Care Pharmacy Partner Program
  • Long Term Care (LTC) Pharmacies who are participating in FRPP will now have access to order Paxlovid and Monulpiravir through the Federal government.
    • Participating LTC pharmacies and FRPP partners include MHA, Omnicare and TigeRx Pharmacy.

Therapeutics Usage & Inventory Reporting Requirements

• VDH is working to develop a redistribution process for therapeutics that are not anticipated to be used. More information to follow.
• Sites with continued non-compliance with usage and inventory reporting may not have their orders fulfilled until they regularly report.
• Reporting for Sotrovimab, Regen-cov, Bam/ETE are due every Wednesday by 11:59PM ET in the U.S. Healthcare COVID-19 Portal (i.e., TeleTracking/NHSN).
  • VDH has published a job aid for the U.S. Healthcare COVID-19 Portal, which can be accessed here.
• Reporting courses administered and daily on-hand for Paxlovid, Molnupiravir, Evusheld and Bebtelovimab are due daily by 11:59pm EDT in the HHS Health Partner Order Portal (HPoP).
  • VDH has published a job aid for the HHS Health Partner Order Portal (HPoP) here.

Therapeutics Return Process for bam/ete and REGEN-COV products